ATE290527T1 - Tetrahydrobenzindol-derivate - Google Patents
Tetrahydrobenzindol-derivateInfo
- Publication number
- ATE290527T1 ATE290527T1 AT98961493T AT98961493T ATE290527T1 AT E290527 T1 ATE290527 T1 AT E290527T1 AT 98961493 T AT98961493 T AT 98961493T AT 98961493 T AT98961493 T AT 98961493T AT E290527 T1 ATE290527 T1 AT E290527T1
- Authority
- AT
- Austria
- Prior art keywords
- hydrogen atom
- integer
- group
- specified substituent
- lower alkyl
- Prior art date
Links
- GHDKZRYOSSRTLA-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1h-benzo[g]indole Chemical class C1C=C2C=CC=CC2=C2C1CCN2 GHDKZRYOSSRTLA-UHFFFAOYSA-N 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 8
- 125000001424 substituent group Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 abstract 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
- C07D209/92—Naphthostyrils
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35838097 | 1997-12-25 | ||
| JP35838197A JPH11189585A (ja) | 1997-12-25 | 1997-12-25 | ５−ｈｔ７受容体結合能を有するテトラヒドロベンズインドール誘導体 |
| JP8591398 | 1998-03-31 | ||
| JP13687298 | 1998-05-19 | ||
| JP22970998 | 1998-08-14 | ||
| JP31933698 | 1998-11-10 | ||
| PCT/JP1998/005827 WO1999033804A1 (fr) | 1997-12-25 | 1998-12-22 | Derives de tetrahydrobenzindole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE290527T1 true ATE290527T1 (de) | 2005-03-15 |
Family
ID=27551662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98961493T ATE290527T1 (de) | 1997-12-25 | 1998-12-22 | Tetrahydrobenzindol-derivate |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6498251B1 (de) |
| EP (1) | EP1057814B1 (de) |
| JP (1) | JP4459437B2 (de) |
| KR (1) | KR100588249B1 (de) |
| CN (1) | CN1129578C (de) |
| AT (1) | ATE290527T1 (de) |
| CA (1) | CA2316388C (de) |
| DE (1) | DE69829317T2 (de) |
| DK (1) | DK1057814T3 (de) |
| ES (1) | ES2238778T3 (de) |
| NO (1) | NO317293B1 (de) |
| WO (1) | WO1999033804A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1081136A4 (de) * | 1998-04-22 | 2002-07-03 | Meiji Seika Kaisha | Optisch aktive tetrahydrobenzindol-derivate |
| UA69420C2 (uk) | 1998-10-06 | 2004-09-15 | Янссен Фармацевтика Н.В. | ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ |
| GB9828004D0 (en) * | 1998-12-18 | 1999-02-10 | Smithkline Beecham Plc | Use |
| HK1049151A1 (zh) * | 1999-10-18 | 2003-05-02 | Smithkline Beecham Plc | 四氫化苯並吲衍生物、其製備方法和用作5-ht7受體拮抗劑的用途 |
| AR035417A1 (es) * | 2001-01-27 | 2004-05-26 | Hoffmann La Roche | Derivados triciclicos de lactama y sultama, procesos para su elaboracion, medicamentos que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos |
| US20060089347A1 (en) * | 2002-08-20 | 2006-04-27 | Eli Lilly And Company | Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses |
| WO2005012310A1 (ja) * | 2003-08-04 | 2005-02-10 | Soda Aromatic Co.,Ltd. | チエノピリジン系化合物の香料における使用、および新規チエノピリジン系化合物 |
| RS20060619A (sr) * | 2004-05-11 | 2008-06-05 | Egis Gyogyszergyar Nyrt., | Piridinski derivati alkil oksindola kao aktivna sredstva koja deluju na 5-ht7 receptor |
| JP2008539267A (ja) * | 2005-04-26 | 2008-11-13 | ハイプニオン・インコーポレイテッド | ベンズイソオキサゾールピペリジン化合物及びその使用方法 |
| AU2007280428B2 (en) * | 2006-08-04 | 2012-04-12 | Merz Pharma Gmbh & Co. Kgaa | Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| EP1956006A1 (de) * | 2007-02-06 | 2008-08-13 | Laboratorios del Dr. Esteve S.A. | Heterocyclisch substituierte Tetrahydronaphthalenderivate als 5-HT7 Rezeptorliganden |
| EP1975161A1 (de) * | 2007-03-28 | 2008-10-01 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituierte Tetrahydronaphthalenamin-Derivate, ihre Herstellung und Verwendung als Arzneimittel |
| CN102083830B (zh) | 2008-03-24 | 2014-11-12 | 梅迪维新技术公司 | 吡啶并[3,4-b]吲哚和应用方法 |
| CA2775129A1 (en) * | 2009-09-23 | 2011-03-31 | Medivation Technologies, Inc. | Pyrido[3,4-b]indoles and methods of use |
| CN108623585B (zh) * | 2018-05-22 | 2021-07-09 | 中国人民解放军第二军医大学 | β-四氢咔啉类抗真菌药物及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE296801T1 (de) | 1996-06-28 | 2005-06-15 | Meiji Seika Kaisha | Tetrahydrobezindol derivate |
| EP1081136A4 (de) | 1998-04-22 | 2002-07-03 | Meiji Seika Kaisha | Optisch aktive tetrahydrobenzindol-derivate |
-
1998
- 1998-12-22 CN CN98813811A patent/CN1129578C/zh not_active Expired - Fee Related
- 1998-12-22 KR KR1020007007122A patent/KR100588249B1/ko not_active Expired - Fee Related
- 1998-12-22 JP JP2000526488A patent/JP4459437B2/ja not_active Expired - Fee Related
- 1998-12-22 ES ES98961493T patent/ES2238778T3/es not_active Expired - Lifetime
- 1998-12-22 CA CA002316388A patent/CA2316388C/en not_active Expired - Fee Related
- 1998-12-22 US US09/582,416 patent/US6498251B1/en not_active Expired - Fee Related
- 1998-12-22 WO PCT/JP1998/005827 patent/WO1999033804A1/ja active IP Right Grant
- 1998-12-22 DE DE69829317T patent/DE69829317T2/de not_active Expired - Lifetime
- 1998-12-22 AT AT98961493T patent/ATE290527T1/de not_active IP Right Cessation
- 1998-12-22 EP EP98961493A patent/EP1057814B1/de not_active Expired - Lifetime
- 1998-12-22 DK DK98961493T patent/DK1057814T3/da active
-
2000
- 2000-06-22 NO NO20003285A patent/NO317293B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010033609A (ko) | 2001-04-25 |
| EP1057814A4 (de) | 2001-07-11 |
| CA2316388C (en) | 2009-09-08 |
| WO1999033804A1 (fr) | 1999-07-08 |
| DE69829317D1 (de) | 2005-04-14 |
| CN1286683A (zh) | 2001-03-07 |
| DK1057814T3 (da) | 2005-07-04 |
| EP1057814B1 (de) | 2005-03-09 |
| CN1129578C (zh) | 2003-12-03 |
| NO20003285L (no) | 2000-08-23 |
| CA2316388A1 (en) | 1999-07-08 |
| JP4459437B2 (ja) | 2010-04-28 |
| NO317293B1 (no) | 2004-10-04 |
| EP1057814A1 (de) | 2000-12-06 |
| DE69829317T2 (de) | 2006-04-06 |
| NO20003285D0 (no) | 2000-06-22 |
| KR100588249B1 (ko) | 2006-06-13 |
| ES2238778T3 (es) | 2005-09-01 |
| US6498251B1 (en) | 2002-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69829317D1 (de) | Tetrahydrobenzindol-derivate | |
| FR2662162B1 (fr) | Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| FI950016A0 (fi) | Heterosykliset yhdisteet lääkeaineena | |
| YU84791A (sh) | Biciklicni 1-aza-cikloalkalni | |
| ATE186724T1 (de) | Substituierte thiazolidindionderivate | |
| EA200800285A1 (ru) | Новые производные 2,4-дианилинопиримидинов, их получение, лекарственные средства, фармацевтические композиции, содержащие указанные производные, и их применение, в частности, в качестве ингибиторов ikk | |
| DE69108138D1 (de) | Imidazopyridinderivate und ihre Verwendung. | |
| ATE88714T1 (de) | 2'-desoxy-5-fluoruridinderivate. | |
| DK0695183T3 (da) | Anvendelse af thiazolidindioner til behandling af atherosklerose og spiseforstyrrelser | |
| EP0604354A3 (de) | Antidepressiv und gegen die Parkinsonsche Krankheit wirkende Verbindungen. | |
| DE69202120D1 (de) | Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie. | |
| FI892637A0 (fi) | Menetelmä valmistaa farmakologisesti arvokasta kefeemiyhdistettä | |
| DK1034174T3 (da) | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer | |
| DE69937045D1 (de) | Cyclische amidderivate | |
| FR2612517B1 (fr) | Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant | |
| CA2203850A1 (en) | Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists | |
| DE69433005D1 (de) | Benzothiazinderivate | |
| FI890293A0 (fi) | Foerfarande foer framstaellning av tioformamidderivat. | |
| HUT76276A (en) | 3-substituted 1-arylindole compounds, pharmaceutical compositions containing them and their use | |
| EP1020451A4 (de) | Neue anilidverbindungen und medikamente, die diese enthalten | |
| DE69626624D1 (de) | Medikamente gegen trhombocytopenie | |
| DE69222143D1 (de) | Indanderivate | |
| FR2632522B1 (fr) | Nouveaux derives de la phenothiazine, leur preparation et les compositions qui les contiennent | |
| DE69401521D1 (de) | Piperidin-Derivate mit antihistaminischer und antileukomenischer Wirkung | |
| TH60675A (th) | การใช้อนุพันธ์ไพริโดอินโดโลนสำหรับการเตรียมผลิตภัณฑ์ยา |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |